Alesta Therapeutics

Leiden, Netherlands · Founded 2021 · Privately Held (backing)

Developer of small-molecule biotech program designed for the development of innovative therapies targeting synthetic lethal metabolic dependencies in cancer. Alesta Therapeutics is based in Leiden, Netherlands and was founded in 2021. It has raised $68.3 million.

Last price · $/share
—
Implied valuation
—
Total raised
$68.3M
Last round
—

Who backs Alesta Therapeutics?

7 investors
InvestorType
Frazier Healthcare PartnersVenture capital
Novartis Venture FundOther
RTW InvestmentsHedge fund
Droia Ventures—
RV Invest—
SSI Strategy—
Thuja Capital Management—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Alesta Therapeutics investors

7 investors are on record for Alesta Therapeutics, including Frazier Healthcare Partners, Novartis Venture Fund, RTW Investments and Droia Ventures.

Free account
More of Alesta Therapeutics with a free account
  • ·Watch Alesta Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Alesta Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View